Hartmann LC - Search Results

1

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.

Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Lawrence JB, et al. Among authors: hartmann lc. Clin Cancer Res. 1997 Oct;3(10):1713-20. Clin Cancer Res. 1997. PMID: 9815555 Clinical Trial.

2

Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.

Ingle JN, Foley JF, Mailliard JA, Krook JE, Hartmann LC, Jung SH, Veeder MH, Gesme DH Jr, Hatfield AK, Goldberg RM. Ingle JN, et al. Among authors: hartmann lc. Cancer. 1994 May 1;73(9):2337-43. doi: 10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co;2-q. Cancer. 1994. PMID: 8168039 Clinical Trial.

3

Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.

Ingle JN, Krook JE, Mailliard JA, Hartmann LC, Wieand HS. Ingle JN, et al. Among authors: hartmann lc. Am J Clin Oncol. 1995 Dec;18(6):498-501. doi: 10.1097/00000421-199512000-00009. Am J Clin Oncol. 1995. PMID: 8526193 Clinical Trial.

4

A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. Ingle JN, et al. Among authors: hartmann lc. Cancer. 1997 Jul 15;80(2):218-24. doi: 10.1002/(sici)1097-0142(19970715)80:2<218::aid-cncr8>3.0.co;2-p. Cancer. 1997. PMID: 9217033 Clinical Trial.

5

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.

Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. Ingle JN, et al. Among authors: hartmann lc. Cancer. 1999 Mar 15;85(6):1284-92. doi: 10.1002/(sici)1097-0142(19990315)85:6<1284::aid-cncr10>3.0.co;2-p. Cancer. 1999. PMID: 10189133 Clinical Trial.

6

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.

Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Peethambaram PP, et al. Among authors: hartmann lc. Breast Cancer Res Treat. 1999 Mar;54(2):117-22. doi: 10.1023/a:1006185805079. Breast Cancer Res Treat. 1999. PMID: 10424402 Clinical Trial.

7

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.

Perez EA, Hillman DW, Stella PJ, Krook JE, Hartmann LC, Fitch TR, Hatfield AK, Mailliard JA, Nair S, Kardinal CG, Ingle JN. Perez EA, et al. Among authors: hartmann lc. Cancer. 2000 Jan 1;88(1):124-31. doi: 10.1002/(sici)1097-0142(20000101)88:1<124::aid-cncr17>3.3.co;2-6. Cancer. 2000. PMID: 10618614 Clinical Trial.

8

Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M, Jones WO, Perez EA, Hartmann LC. Grant CS, et al. Among authors: hartmann lc. J Clin Oncol. 2009 Aug 1;27(22):3620-6. doi: 10.1200/JCO.2008.21.3603. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487378 Free PMC article. Clinical Trial.

9

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors.

Wahner Hendrickson AE, Menefee ME, Hartmann LC, Long HJ, Northfelt DW, Reid JM, Boakye-Agyeman F, Kayode O, Flatten KS, Harrell MI, Swisher EM, Poirier GG, Satele D, Allred J, Lensing JL, Chen A, Ji J, Zang Y, Erlichman C, Haluska P, Kaufmann SH. Wahner Hendrickson AE, et al. Among authors: hartmann lc. Clin Cancer Res. 2018 Feb 15;24(4):744-752. doi: 10.1158/1078-0432.CCR-17-1590. Epub 2017 Nov 14. Clin Cancer Res. 2018. PMID: 29138343 Free PMC article. Clinical Trial.

10

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.

Hartmann LC, Ingle JN, Wold LE, Farr GH Jr, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, Roche PC. Hartmann LC, et al. Cancer. 1994 Dec 1;74(11):2956-63. doi: 10.1002/1097-0142(19941201)74:11<2956::aid-cncr2820741111>3.0.co;2-v. Cancer. 1994. PMID: 7954259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters